Preliminary Results | 28-May-2025 | 07:00 | RNS |
Notice of Results | 23-May-2025 | 07:00 | RNS |
Issue of LTIP Options and Share Options | 21-Mar-2025 | 07:00 | RNS |
Results of Eisai Phase 2 pilot study | 21-Mar-2025 | 07:00 | RNS |
Analysis of CTC-DNA and ctDNA using Illumina assay | 29-Jan-2025 | 07:00 | RNS |
Trading Update | 23-Jan-2025 | 07:00 | RNS |
Half-year Report | 26-Sep-2024 | 07:00 | RNS |
Exclusive agreement for DNA NGS panel | 23-Sep-2024 | 07:00 | RNS |
Notice of Interim Results and Webcast | 17-Sep-2024 | 07:00 | RNS |
Standard form for notification of major holdings | 18-Jul-2024 | 10:08 | RNS |
Standard form for notification of major holdings | 12-Jul-2024 | 15:38 | RNS |
Result of 2024 Annual General Meeting | 11-Jul-2024 | 15:07 | RNS |
Result of open offer | 21-Jun-2024 | 07:00 | RNS |
Posting of 2023 Annual Report & Notice of the AGM | 18-Jun-2024 | 14:41 | RNS |
Publication of Circular | 06-Jun-2024 | 16:37 | RNS |
Currency | UK Pounds |
Share Price | 7.50p |
Change Today | -0.50p |
% Change | -6.25 % |
52 Week High | 18.72 |
52 Week Low | 7.00 |
Volume | 2,193,987 |
Shares Issued | 322.64m |
Market Cap | £24.20m |
Beta | 0.18 |
RiskGrade | 312 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 1 |
Buy | 0 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
Time | Volume / Share Price |
17:05 | 305,000 @ 7.50p |
16:42 | 50,000 @ 7.50p |
15:54 | 5,000 @ 7.59p |
15:51 | 21,658 @ 7.38p |
15:49 | 32,950 @ 7.56p |
CEO | Andrew D Newland |
Finance Director | Ian F Griffiths |
Chair | Jan Groen |
You are here: research